Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Applied Biosystems and Deloitte Consulting LLP Announce a Strategic Alliance to Provide Comprehensive Informatics Solutions to the Life Science Marketplace
- FOSTER CITY, Calif. -- Solutions to Be Designed for Life Science Research and Development, Clinical Research, and Forensics Laboratories
- Research articles 2005-02-28
- Ex-state official now Deloitte & Touche agent.(Brief Article)
- LANSING - For nearly 14 years, Al Aceves was in state government, working with companies on economic-development projects and potential state aid. Now, he's on the opposite side of the negotiating table. Aceves, a former deputy director and account LANSING - For nearly 14...
- Research articles 2000-04-17
- Strategic Flexibility in Life Sciences: From Discovering the Unknown to Exploiting the Uncertain
- The life sciences industry is being rocked simultaneously by seismic changes in its market and the larger scientific environment. The industry faces twin challenges: increasing competition and greater uncertainty about the specific conditions that will accompany it - making it extremely difficult for management to craft the optimal strategic response....
- White papers 2002-09-05
- Fraud Risk Management in Life Sciences
- The Food and Drug Administration FDA estimates that counterfeit products make up more than 10 percent of the global pharmaceuticals supply. Whether it is counterfeit products slipping into the supply chain or employees engaging in unlawful pricing activities, fraud costs life sciences companies billions of dollars annually. Implementation of sufficiently...
- White papers 2007-09-09
- Health Information Technology Value Chain: A Life Sciences Perspective
- This Deloitte report discusses health information revolution. This point of view addresses the major challenges that life sciences companies are facing such as falling research and development productivity, lengthy clinical trials, growing regulatory scrutiny in new medicines and the lack of deep insights into the needs for pharmacogenics products. It...
- White papers 2008-05-19
- Focusing On M&A In Healthcare And Life Sciences: A Conversation With Philip E. Pfrang
- As the National Healthcare & Life Sciences Industry Leader of Deloitte's M&A Transaction Services, Philip E. Pfrang has advised clients on more than 400 completed and proposed transactions and has extensive experience in cross-border and multinational deals. Directorship spoke with Pfrang about trends in the healthcare and life-sciences marketplace and...
- White papers 2008-08-22
- Linking Improvement To Transformation: A Global Manufacturing Strategy For Life Sciences
- Life sciences companies are at a critical point in time. Business models that had yielded profitable growth for years face mounting challenges such as increased competition, more demanding patients and payors, and a constantly evolving regulatory environment. Leaders at companies experiencing growth and those where it is stalled all face...
- White papers 2008-05-15
- Opportunities For Life Sciences Companies In A Consumer-Driven Market
- As consumers assume more personal responsibility for covering their health care costs, and gain increased awareness of treatment options, provider quality levels and price differences, they will want to take even greater control of their medical care decisions. Life sciences companies that recognize that consumerism is here to stay, and...
- White papers 2008-08-29
- Fraud Risk Management In Life Sciences Companies
- Although many life sciences companies are beginning to put controls in place, many have yet to bring together all the necessary ingredients for identifying and preventing fraud. Among other challenges, it is imperative that legal, accounting, marketing, and contracts professionals within an organization collaborate on all fronts to document, monitor,...
- White papers 2007-08-22
- Contract Administration, Rebates, And Chargebacks For The Life Sciences Industry
- Life sciences manufacturers typically secure the business of key customers and distribution channels through contracting. However, as health care cost containment pressures continue to grow, the need to aggressively contract with payors, wholesalers, and Group Purchasing Organizations GPOs has intensified. As a result of aggressive and creative contracting, terms such...
- White papers 2008-11-06
- Customer And Reimbursement Support For The Life Sciences Industry: The Need For An evolved Approach
- Customer and Reimbursement Support are among the only forms of direct contact that life sciences companies have with their patients. Developing and strengthening these relationships are increasingly important in nowadays' consumerdriven health system. Particularly in therapeutic areas involving chronic diseases, such relationships can improve the lifetime value of end customers...
- White papers 2008-11-06
- Greening And Sustainability In Health Care And Life Sciences: Implementing A Strategic Response
- Greening is not a fad; it is a long-term trend that will require every health care organization to invest strategically and programmatically to conserve natural resources and create a healthy environment for customers, patients and employees. For many industries, greening has been a longstanding challenge: automakers and air pollution, chemical...
- White papers 2009-02-13
- Innovation In The Life Sciences Industry: Results From A Survey Of Life Sciences & Health Care Executives
- Innovation in the life sciences industry defined as any new product introduced to the market that improves upon existing products either incrementally or fundamentally is vital for meeting growing consumer demand for more effective and affordable health care solutions. Innovation is also critical to life sciences companies for establishing a...
- White papers 2007-01-10
Additional Resources
- GenVec Named to Deloitte's Technology Fast 50 for Maryland
- GAITHERSBURG, Md. -- GenVec, Inc. (Nasdaq: GNVC) has been named one of Maryland's fifty fastest growing technology, media, telecommunications and life science companies by Deloitte & Touche USA LLP, one of the nation's leading professional services organizations. Rankings in Deloitte's Technology Fast 50 Program are based on the percentage revenue...
- Research articles 2007-10-03
- New Strategies Needed for Life Sciences Industry
- ACCORDING TO a recent Deloitte Touche Tohmatsu DTT survey of executives in the life sciences industry, their businesses are poised to undergo dramatic change in the next decade. This change will be driven by shifts in demographics, disease, new technologies, and the pace of healthcare inflation. "Over the next decade,...
- Research articles 2007-02-01
- << Previous
- page 1 of 1
- Next >>
